Literature DB >> 35521028

Drug Reaction with Eosinophilia and Systemic Symptoms and Agranulocytosis Presenting as Cervical Lymphadenopathy.

Laura Chen1, Clemente Chia1, Anik Saha1.   

Abstract

Objective: Drug reaction with eosinophilia and systemic symptoms (DRESS) is a rare cause of cervical lymphadenopathy. It is a potentially life-threatening hypersensitivity reaction, commonly characterized by fever, rash, hematological abnormalities, and multi-organ involvement. Its association with agranulocytosis is even rarer, with fewer than 10 cases describing the coexistence of DRESS with agranulocytosis reported in the English literature. Case Summary: An otherwise well 40-year-old female presented with a sore throat and cervical lymphadenopathy, with investigations revealing DRESS and agranulocytosis secondary to carbamazepine.
Conclusion: DRESS and agranulocytosis are serious, potentially life-threatening adverse drug reactions which can initially present as cervical lymphadenopathy. As carbamazepine is considered first-line therapy for certain chronic neuropathic conditions such as trigeminal neuralgia, clinicians should be aware of the varying clinical presentations of both conditions.
© The Author(s) 2021.

Entities:  

Keywords:  DRESS; agranulocytosis; carbamazepine; drug reaction with eosinophilia and systemic symptoms; drug-induced hypersensitivity reaction

Year:  2021        PMID: 35521028      PMCID: PMC9065511          DOI: 10.1177/0018578721990899

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  18 in total

1.  Ceftobiprole associated agranulocytosis after drug rash with eosinophilia and systemic symptoms induced by vancomycin and rifampicin.

Authors:  Thomas Wendland; Barbara Daubner; Werner J Pichler
Journal:  Br J Clin Pharmacol       Date:  2011-02       Impact factor: 4.335

2.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

3.  Careful monitoring for agranulocytosis during carbamazepine treatment.

Authors:  Joan M Daughton; Prasad R Padala; Teri L Gabel
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

4.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  S H Kardaun; A Sidoroff; L Valeyrie-Allanore; S Halevy; B B Davidovici; M Mockenhaupt; J C Roujeau
Journal:  Br J Dermatol       Date:  2007-03       Impact factor: 9.302

5.  Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Authors:  H Peyrière; O Dereure; H Breton; P Demoly; M Cociglio; J-P Blayac; D Hillaire-Buys
Journal:  Br J Dermatol       Date:  2006-08       Impact factor: 9.302

Review 6.  Drug reaction with eosinophilia and systemic symptoms (DRESS): incidence, pathogenesis and management.

Authors:  Tetsuo Shiohara; Yoko Kano
Journal:  Expert Opin Drug Saf       Date:  2016-12-21       Impact factor: 4.250

Review 7.  The DRESS syndrome: a literature review.

Authors:  Patrice Cacoub; Philippe Musette; Vincent Descamps; Olivier Meyer; Chris Speirs; Laetitia Finzi; Jean Claude Roujeau
Journal:  Am J Med       Date:  2011-05-17       Impact factor: 4.965

Review 8.  Management of Psychotropic Drug-Induced DRESS Syndrome: A Systematic Review.

Authors:  Tanner J Bommersbach; Maria I Lapid; Jonathan G Leung; Julie L Cunningham; Teresa A Rummans; Simon Kung
Journal:  Mayo Clin Proc       Date:  2016-04-25       Impact factor: 7.616

9.  Oxacillin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS).

Authors:  Alexis Sharpe; Bashar M Mourad; Chase J Hardwick; Theresa Reilly; Ezra Dweck; Eric Bondarsky
Journal:  Am J Case Rep       Date:  2019-03-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.